Moreover, in addition to sLAG3, sPDL1 and sIL8 resulted as predictive biomarkers of response only when the analyses were carried out in the overall NSCLC population, suggesting that the release of these soluble molecules could be induced by other therapies such as chemotherapy. This evidence concerns the gene SPDL1 and non-small cell lung carcinoma.